BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38081154)

  • 1. Comparison of Monotherapies and Combination Therapy of Tamsulosin and Tadalafil for Treating Lower Urinary Tract Symptoms Caused by Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Meta-Analysis.
    Liu J; Zhou W; Zhang P; Zhang W; Chang C; Fu G
    Urol Int; 2024; 108(2):89-99. PubMed ID: 38081154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Singh DV; Mete UK; Mandal AK; Singh SK
    J Sex Med; 2014 Jan; 11(1):187-96. PubMed ID: 24165272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
    Kim SW; Park NC; Lee SW; Yang DY; Park JK; Moon DG; Yang SK; Lee SW; Moon KH; Ahn TY; Kim SW; Park K; Min KS; Ryu JK; Son H; Jung J; Hyun JS
    J Sex Med; 2017 Aug; 14(8):1018-1027. PubMed ID: 28760246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to Monotherapies, in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Associated With Benign Prostatic Hyperplasia: A Meta-Analysis.
    Sun K; Sun F; Yao H; Zhang D; Wu G; Wang T; Wang J; Wu J
    Am J Mens Health; 2020; 14(6):1557988320980180. PubMed ID: 33342335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis of Efficacy and Safety of Tadalafil Plus Tamsulosin Compared with Tadalafil Alone in Treating Men with Benign Prostatic Hyperplasia and Erectile Dysfunction.
    Zhou Z; Zheng X; Wu J; Gao Z; Xu Z; Cui Y
    Am J Mens Health; 2019; 13(5):1557988319882597. PubMed ID: 31625449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial.
    Sebastianelli A; Spatafora P; Frizzi J; Saleh O; De Nunzio C; Tubaro A; Vignozzi L; Maggi M; Serni S; McVary KT; Kaplan SA; Gravas S; Chapple C; Gacci M
    Eur Urol Focus; 2021 Mar; 7(2):432-439. PubMed ID: 31606473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review and Meta-Analysis of the Efficacy and Safety of Tamsulosin Plus Tadalafil Compared With Tamsulosin Alone in Treating Males With Lower Urinary Tract Symptoms Secondary to Benign Prostrate Hyperplasia.
    Zhou R; Che X; Zhou Z; Ma Y
    Am J Mens Health; 2023; 17(1):15579883231155096. PubMed ID: 36842963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study.
    Bechara A; Romano S; Casabé A; Haime S; Dedola P; Hernández C; Rey H
    J Sex Med; 2008 Sep; 5(9):2170-8. PubMed ID: 18638006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Tadalafil versus Tamsulosin in Treating Lower Urinary Tract Symptoms Suggestive of Benign Prostate Hyperplasia: A Meta-Analysis of Randomized Controlled Trials.
    Guo B; Chen X; Wang M; Hou H; Zhang Z; Liu M
    Med Sci Monit; 2020 Apr; 26():e923179. PubMed ID: 32327621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED.
    Sebastianelli A; Spatafora P; Morselli S; Vignozzi L; Serni S; McVary KT; Kaplan S; Gravas S; Chapple C; Gacci M
    Curr Urol Rep; 2020 Oct; 21(12):56. PubMed ID: 33108544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Monotherapy with Tadalafil or Tamsulosin and Their Combination Therapy in Men with Benign Prostatic Hyperplasia: A Randomized Clinical Trial.
    Karami H; Hassanzadeh-Hadad A; Fallah-Karkan M
    Urol J; 2016 Dec; 13(6):2920-2926. PubMed ID: 27928815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of tadalafil vs tamsulosin in lower urinary tract symptoms (LUTS) as a result of benign prostate hyperplasia (BPH)-open label randomised controlled study.
    Singh I; Tk A; Gupta S
    Int J Clin Pract; 2020 Aug; 74(8):e13530. PubMed ID: 32542854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis.
    Ma C; Zhang J; Cai Z; Xiong J; Li H
    Biomed Res Int; 2020; 2020():1419520. PubMed ID: 32309423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamsulosin and placebo vs tamsulosin and tadalafil in male lower urinary tract symptoms: a double-blinded, randomised controlled trial.
    Nagasubramanian S; John NT; Antonisamy B; Mukha RP; Jeyachandra Berry CS; Kumar S; Devasia A; Kekre NS
    BJU Int; 2020 May; 125(5):718-724. PubMed ID: 32012409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial.
    Oelke M; Giuliano F; Mirone V; Xu L; Cox D; Viktrup L
    Eur Urol; 2012 May; 61(5):917-25. PubMed ID: 22297243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome.
    Sebastianelli A; Morselli S; Spatafora P; Liaci A; Gemma L; Zaccaro C; Vignozzi L; Maggi M; McVary KT; Kaplan SA; Chapple C; Gravas S; Serni S; Gacci M
    Minerva Urol Nephrol; 2021 Dec; 73(6):836-844. PubMed ID: 33200905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
    AbdelRazek M; Abolyosr A; Mhammed O; Fathi A; Talaat M; Hassan A
    World J Urol; 2022 Aug; 40(8):2063-2070. PubMed ID: 35773357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of tadalafil 5 mg once daily in the treatment of men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction: results from naturalistic observational TadaLutsEd study.
    Bechara A; Casabe A; Rodriguez Baigorri G; Cobreros C
    J Sex Med; 2014 Feb; 11(2):498-505. PubMed ID: 24224728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
    Giuliano F; Oelke M; Jungwirth A; Hatzimouratidis K; Watts S; Cox D; Viktrup L
    J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.